Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 20 of 64

1.

The effects of feedback and incentive-based insurance on driving behaviours: study approach and protocols.

Stevenson M, Harris A, Mortimer D, Wijnands JS, Tapp A, Peppard F, Buckis S.

Inj Prev. 2017 Jan 10. pii: injuryprev-2016-042280. doi: 10.1136/injuryprev-2016-042280. [Epub ahead of print]

2.

Vaginal progesterone prophylaxis for preterm birth (the OPPTIMUM study): a multicentre, randomised, double-blind trial.

Norman JE, Marlow N, Messow CM, Shennan A, Bennett PR, Thornton S, Robson SC, McConnachie A, Petrou S, Sebire NJ, Lavender T, Whyte S, Norrie J; OPPTIMUM study group..

Lancet. 2016 May 21;387(10033):2106-16. doi: 10.1016/S0140-6736(16)00350-0.

3.

Adolescent self-harm in the community: an update on prevalence using a self-report survey of adolescents aged 13-18 in England.

Morey Y, Mellon D, Dailami N, Verne J, Tapp A.

J Public Health (Oxf). 2016 Feb 17. pii: fdw010. [Epub ahead of print]

PMID:
26892623
4.

Multidimensional individualised Physical ACTivity (Mi-PACT)--a technology-enabled intervention to promote physical activity in primary care: study protocol for a randomised controlled trial.

Peacock OJ, Western MJ, Batterham AM, Stathi A, Standage M, Tapp A, Bennett P, Thompson D.

Trials. 2015 Aug 28;16:381. doi: 10.1186/s13063-015-0892-x.

5.

Quetiapine for the treatment of cocaine use disorder.

Tapp A, Wood AE, Kennedy A, Sylvers P, Kilzieh N, Saxon AJ.

Drug Alcohol Depend. 2015 Apr 1;149:18-24. doi: 10.1016/j.drugalcdep.2014.12.037.

PMID:
25682480
6.

The utility of the Dementia Severity Rating Scale in differentiating mild cognitive impairment and Alzheimer disease from controls.

Mitchell JC, Dick MB, Wood AE, Tapp AM, Ziegler R.

Alzheimer Dis Assoc Disord. 2015 Jul-Sep;29(3):222-8. doi: 10.1097/WAD.0000000000000057.

7.

Differences in treatment effect among clinical subgroups in a randomized clinical trial of long-acting injectable risperidone and oral antipsychotics in unstable chronic schizophrenia.

Leatherman SM, Liang MH, Krystal JH, Lew RA, Valley D, Thwin SS, Rosenheck RA; CSP 555 Investigators..

J Nerv Ment Dis. 2014 Jan;202(1):13-7. doi: 10.1097/NMD.0000000000000069.

PMID:
24375206
8.

Wheels, skills and thrills: a social marketing trial to reduce aggressive driving from young men in deprived areas.

Tapp A, Pressley A, Baugh M, White P.

Accid Anal Prev. 2013 Sep;58:148-57. doi: 10.1016/j.aap.2013.04.023.

PMID:
24001339
9.

Cost and cost-effectiveness in a randomized trial of long-acting risperidone for schizophrenia.

Barnett PG, Scott JY, Krystal JH, Rosenheck RA; CSP 555 Research Group..

J Clin Psychiatry. 2012 May;73(5):696-702. doi: 10.4088/JCP.11m07070.

PMID:
22697193
10.

Effectiveness of switching from long-acting injectable fluphenazine or haloperidol decanoate to long-acting injectable risperidone microspheres: an open-label, randomized controlled trial.

Covell NH, McEvoy JP, Schooler NR, Stroup TS, Jackson CT, Rojas IA, Essock SM; Schizophrenia Trials Network..

J Clin Psychiatry. 2012 May;73(5):669-75. doi: 10.4088/JCP.11m07074.

11.

Mastermind mutations generate a unique constellation of midline cells within the Drosophila CNS.

Zhang Y, Wheatley R, Fulkerson E, Tapp A, Estes PA.

PLoS One. 2011;6(10):e26197. doi: 10.1371/journal.pone.0026197.

12.

Concomitant psychotropic medication use during treatment of schizophrenia patients: longitudinal results from the CATIE study.

Chakos M, Patel JK, Rosenheck R, Glick ID, Hammer MB, Tapp A, Miller A, Miller D.

Clin Schizophr Relat Psychoses. 2011 Oct;5(3):124-34. doi: 10.3371/CSRP.5.3.2. Erratum in: Clin Schizophr Relat Psychoses. 2012 Jan;5(4):184. Miller, Del [added].

PMID:
21983496
13.

Evaluating the twin testosterone transfer hypothesis: a review of the empirical evidence.

Tapp AL, Maybery MT, Whitehouse AJ.

Horm Behav. 2011 Nov;60(5):713-22. doi: 10.1016/j.yhbeh.2011.08.011. Review.

PMID:
21893061
14.

Substance use and schizophrenia: adverse correlates in the CATIE study sample.

Kerfoot KE, Rosenheck RA, Petrakis IL, Swartz MS, Keefe RS, McEvoy JP, Stroup TS; CATIE Investigators..

Schizophr Res. 2011 Nov;132(2-3):177-82. doi: 10.1016/j.schres.2011.07.032.

PMID:
21872443
15.

Effectiveness of switching from antipsychotic polypharmacy to monotherapy.

Essock SM, Schooler NR, Stroup TS, McEvoy JP, Rojas I, Jackson C, Covell NH; Schizophrenia Trials Network..

Am J Psychiatry. 2011 Jul;168(7):702-8. doi: 10.1176/appi.ajp.2011.10060908.

16.

How do clinical trial participants compare to other patients with schizophrenia?

Barnett PG, Scott JY, Rosenheck RA; CSP 555 Study Group..

Schizophr Res. 2011 Aug;130(1-3):34-9. doi: 10.1016/j.schres.2011.03.033.

PMID:
21514794
17.

Long-acting risperidone and oral antipsychotics in unstable schizophrenia.

Rosenheck RA, Krystal JH, Lew R, Barnett PG, Fiore L, Valley D, Thwin SS, Vertrees JE, Liang MH; CSP555 Research Group..

N Engl J Med. 2011 Mar 3;364(9):842-51. doi: 10.1056/NEJMoa1005987. Erratum in: N Engl J Med. 2011 Mar 31;364(13):1281.

18.

Challenges in the design and conduct of controlled clinical effectiveness trials in schizophrenia.

Rosenheck RA, Krystal JH, Lew R, Barnett PG, Thwin SS, Fiore L, Valley D, Huang GD, Neal C, Vertrees JE, Liang MH; CSP 555 Research Group..

Clin Trials. 2011 Apr;8(2):196-204. doi: 10.1177/1740774510392931.

PMID:
21270143
19.

Pyrrolidine dithiocarbamate (PDTC) blocks apoptosis and promotes ionizing radiation-induced necrosis of freshly-isolated normal mouse spleen cells.

Thompson JS, Asmis R, Tapp AA, Nelson B, Chu Y, Glass J, Moneyhon M, Brown SA.

Apoptosis. 2010 Jun;15(6):705-14. doi: 10.1007/s10495-010-0487-7.

PMID:
20333468
20.

The manganese superoxide dismutase mimetic, M40403, protects adult mice from lethal total body irradiation.

Thompson JS, Chu Y, Glass J, Tapp AA, Brown SA.

Free Radic Res. 2010 May;44(5):529-40. doi: 10.3109/10715761003649578.

PMID:
20298121

Supplemental Content

Loading ...
Support Center